Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.

MLA

Donohue JF, et al. “Comparison of Levalbuterol and Racemic Albuterol in Hospitalized Patients with Acute Asthma or COPD: A 2-Week, Multicenter, Randomized, Open-Label Study.” Clinical Therapeutics, vol. 30, no. Theme Issue, June 2008, pp. 989–1002. EBSCOhost, https://doi.org/10.1016/j.clinthera.2008.06.010.

APA

Donohue JF, Hanania NA, Ciubotaru RL, Noe L, Pasta DJ, Schaefer K, Claus R, Andrews WT, & Roach J. (2008). Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study. Clinical Therapeutics, 30(Theme Issue), 989–1002. https://doi.org/10.1016/j.clinthera.2008.06.010

Chicago

Donohue JF, Hanania NA, Ciubotaru RL, Noe L, Pasta DJ, Schaefer K, Claus R, Andrews WT, and Roach J. 2008. “Comparison of Levalbuterol and Racemic Albuterol in Hospitalized Patients with Acute Asthma or COPD: A 2-Week, Multicenter, Randomized, Open-Label Study.” Clinical Therapeutics 30 (Theme Issue): 989–1002. doi:10.1016/j.clinthera.2008.06.010.